Larisa Geskin, M.D.
Department of Dermatology
University of Pittsburgh
Presby South Tower, Suite 3880
200 Lothrop St.
Pittsburgh, PA 15213
Dr. Geskin, Director of the Department of Dermatology Cutaneous Oncology Center focuses on immunotherapy for melanoma and cutaneous T cell lymphoma. In collaboration with other members of the UPCI Melanoma Program, Dr. Geskin conducts and evaluates clinical trials of dendritic cell vaccines for melanoma and cutaneous lymphomas. In addition, she is a co-investigator of several epidemiological and clinical studies that test novel therapeutic agents for melanoma and other cutaneous malignancies.
Akilov OE, Pillai R, Grandinetti L, Kant J, Geskin LJ (2011). Clonal T-cell receptor β-chain gene rearrangements in differential diagnostics of lymphomatoid papulosis from skin metastasis of nodal anaplastic large cell lymphoma. Arch. Dermatology, 147 (8):943-947.
Talpur R, Demierre MF, Geskin L, Baron E, Pugliese S, Eubank K, Zic JA, Miller DR, Tharp M, Bohjanen K, Duvic M (2011). Multicenter photopheresis intervention trial in early-stage mycosis fungoides. Clin Lymphoma Myeloma Leuk, (2):219-227.
Akilov OE, Wu MX, Jin Y, Zhou Z, Geskin LJ, Falo LD, Hasan T (2011). Vaccination with photodynamic therapy-treated macrophages induces highly suppressive T-regulatory cells. Photodermatol Photoimmunol Photomed, 27(2):97-107.
Mirvish ED, Pomerantz RG, Geskin LJ (2011). Infectious agents in cutaneous T-cell lymphoma. Am Acad Dermatol, 64(2):423-431.